Medtronic’s (NYSE:MDT) India-based subsidiary announced a strategic partnership with Stasis Health and its AI-based bedside monitoring system. India Medtronic Private Limited and Stasis Health (a wholly-owned subsidiary of Stasis Labs) partnered to scale up and expand access to the Stasis Monitor, a connected care bedside multi-parameter monitoring system, according to a news release. The Stasis […]
Medtronic
MedTech 100 roundup: Industry reaches another high point
The medtech industry is continuing its massive 2021 boom, with the past week marking yet another record in the markets. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 27) at 121.05 points, representing a 1.2% rise from the 119.63-point mark set a week before. […]
Medtronic touts real-world data for Micra leadless pacemaker
Medtronic (NYSE:MDT) today touted data demonstrating reductions in reinterventions and complications with its Micra pacemaker. Fridley, Minn.-based Medtronic’s Micra Coverage with Evidence Development (CED) study, which it labeled the largest evaluation of leadless pacemakers to date, showed that the Micra transcatheter pacing system (TPS) was associated with a 38% reduction in reinterventions and a 31% […]
Medtronic CEO Geoff Martha touts progress on renal denervation and Hugo robotics
Medtronic (NYSE: MDT) is boosting its research and development spending in fiscal year 2022 by more than 10%, which CEO Geoff Martha described as the largest dollar increase ever for the Fridley, Minn.-based medtech giant. “The investments we’re making in our pipeline will play a key role in accelerating our top-line growth, and we’re at […]
FDA approves Medtronic next-gen Evolut FX TAVR system
Medtronic today announced that its Evolut FX TAVR system has won FDA approval. Fridley, Minn.–based Medtronic designed the self-expanding transcatheter aortic valve replacement system to treat symptomatic severe aortic stenosis. Get the full story on our sister site, Medical Tubing + Extrusion.
Medtronic beats The Street on 23% sales growth in Q1
Medtronic (NYSE:MDT) posted first-quarter results today that beat the overall consensus on Wall Street and updated its full-year guidance. The Fridley, Minn.–based company reported profits of $769 million, or 56¢ per share, on sales of $7.98 billion for the three months ended July 30, for a bottom-line gain of 56.6% on sales growth of 22.74% […]
How Medtronic fit a battery into a tiny pacemaker
Medtronic’s Micra pacemakers are one-tenth the size of what was previously out there. How the medtech giant did it provides lessons for anyone looking to shrink an implantable device. It was an all-hands-on-deck effort that consumed Medtronic in the early 2010s: the in-house creation of a pacemaker small enough to go inside the heart via […]
ProPublica report raises questions about FDA’s handling of Medtronic’s HVAD
A recent ProPublica report highlighted potential failings by the FDA in the handling of Medtronic’s HVAD system. In June, Medtronic stopped distributing and selling its HeartWare Ventricular Assist Device (HVAD) system amid a slew of clinical comparisons indicating a higher frequency of neurological adverse events, including stroke and mortality, with the HVAD system. The company had previously recalled […]
MedTech 100 roundup: Industry ticks up again
The medtech industry has been rising for weeks and the latest seven-day stretch was no exception as stocks ticked up again. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 6) at 119.41 points, marking a 0.5% rise from the previous week’s tally of 118.86 […]
Medtronic to acquire Intersect ENT in $1.1B deal
Medtronic (NYSE:MDT) today announced that it has entered a definitive agreement to acquire Intersect ENT (NSDQ:XENT) for $1.1 billion. Medtronic will acquire all outstanding shares of the Menlo Park, Calif.-based sinus implant maker for $28.25 per share in an all-cash transaction. The deal is expected to close toward the end of Medtronic’s 2021–22 fiscal year, subject to […]
HeartFlow appoints former Medtronic executive as COO
HeartFlow today announced that it has appointed John Farquhar as chief operating officer, effective immediately. Farquhar will be responsible for executing the strategic vision of the Redwood City, Calif.–based company — developer of the non-invasive HeartFlow FFRCT analysis. “We are thrilled to add an executive of John’s caliber and accomplishments to the HeartFlow leadership team,” […]